Clinical Trial Update

Category
Continent
From
To
 
Boehringer Starts Phase II Trial for Oral Drug in...

Boehringer Starts Phase II Trial for Oral Drug in...

Category : Clinical Trial Update 9 May 2025

Boehringer Ingelheim announces the start of the JADE phase II clinical study (NCT06769048), investig...
Data from Its Ongoing Phase 2 ENSURE Study at EASL...

Data from Its Ongoing Phase 2 ENSURE Study at EASL...

Category : Clinical Trial Update 8 May 2025

End of treatment (EOT) data from Cohort 4 of the ENSURE study suggest that patients responding to pr...
Genprex inks sponsored research agreement with the...

Genprex inks sponsored research agreement with the...

Category : Clinical Trial Update 8 May 2025

Genprex, Inc. (Genprex), a clinical-stage gene therapy company, announced that following the recent...
J&J Shares New Tremfya Phase 3 Data for Ulcerative...

J&J Shares New Tremfya Phase 3 Data for Ulcerative...

Category : Clinical Trial Update 7 May 2025

Johnson & Johnson announced new data from the Tremfya (guselkumab) phase 3 QUASAR long-term exte...
AGC Biologics, Novelty Nobility Partner for Antibo...

AGC Biologics, Novelty Nobility Partner for Antibo...

Category : Clinical Trial Update 7 May 2025

Today we unveiled a multiphase partnership with Novelty Nobility Inc., a clinical-stage biotech comp...

Categories

Latest Newsletter Post

Subscribe to Our Newsletter!

Subscribe to get latest updates and information.

Welcome Back Sign in to Continue

Don't Have an Account? Sign Up!
Forgot Password?

Create your Account!